NanoCell Therapeutics
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$4.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NanoCell Therapeutics operates in Healthcare & Life Sciences and is based in Wayne, Pennsylvania. Its latest recorded funding round was a Grant round in August 2025.
NanoCell Therapeutics is a biotechnology company that develops non-viral, DNA-based in vivo gene therapy platforms for the treatment of oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoCell Therapeutics Comparables
Compare NanoCell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensoma | 82% | |
| Aera Therapeutics | 82% | |
| Gilead Sciences | 82% |
For institutional investors. Book with your work email.
NanoCell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Seed | Jun 16, 2025 | ||||
| Grant | Jan 4, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NanoCell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eureka Network | Grant |
| Institute for Follicular Lymphoma Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 33% MoM.
- Jun 21, 2026
Monthly visitors grew 149% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
NanoCell Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoCell Therapeutics's valuation, stock price, and market status.
Is NanoCell Therapeutics a public or private company?
NanoCell Therapeutics is a private company.
What is the current stock price of NanoCell Therapeutics?
NanoCell Therapeutics is a private company, so its shares have no public market price. Caplight tracks NanoCell Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoCell Therapeutics worth (valuation)?
Valuation information for NanoCell Therapeutics is not publicly available.
Can I buy NanoCell Therapeutics stock?
NanoCell Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoCell Therapeutics's last funding round?
NanoCell Therapeutics's most recent funding round was Grant on August 14, 2025.
Who are the main investors in NanoCell Therapeutics?
Key investors in NanoCell Therapeutics include Eureka Network, Institute for Follicular Lymphoma Innovation.
Will NanoCell Therapeutics IPO soon?
No public IPO plans have been announced for NanoCell Therapeutics.
How can I track NanoCell Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NanoCell Therapeutics's shares on secondary markets.